Abstract |
1,1-Bis-(3'-indolyl)-1-(p-substitutedphenyl)methanes containing p-trifluoromethyl (DIM-C-pPhCF3), p-t-butyl ( DIM-C-pPhtBu), and phenyl (DIM-C-pPhC6H5) substituents decrease survival of HCT-116 colon cancer cells and activate peroxisome proliferator-activated receptor ( PPAR) gamma in this and other cancer cell lines. These PPARgamma-active compounds had minimal effects on expression of cell cycle proteins and did not induce caveolin-1 in HCT-116 cells. However, these compounds induced nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) and apoptosis in HCT-116 cells, and in time-course studies, the PPARgamma agonists maximally induced early growth response-1 (Egr-1) protein within 2 h, whereas a longer time course was observed for induction of NAG-1 protein. These data, coupled with deletion and mutation analysis of both the Egr-1 and NAG-1 gene promoters, indicate that activation of NAG-1 by these compounds was dependent on prior induction of Egr-1, and induction of these responses was PPARgamma-independent. Results of kinase inhibitor studies also demonstrated that activation of Egr-1/NAG-1 by methylene-substituted diindolylmethanes (C-DIMs) was phosphatidylinositol 3-kinase-dependent, and this represents a novel receptor-independent pathway for C-DIM-induced growth inhibition and apoptosis in colon cancer cells.
|
Authors | Sudhakar Chintharlapalli, Sabitha Papineni, Seung Joon Baek, Shengxi Liu, Stephen Safe |
Journal | Molecular pharmacology
(Mol Pharmacol)
Vol. 68
Issue 6
Pg. 1782-92
(Dec 2005)
ISSN: 0026-895X [Print] United States |
PMID | 16155208
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 1,1-bis(3'-indolyl)-1-(4-biphenyl)methane
- 1,1-bis(3'-indolyl)-1-(4-t-butylphenyl)methane
- 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane
- Cytokines
- EGR1 protein, human
- Early Growth Response Protein 1
- GDF15 protein, human
- Growth Differentiation Factor 15
- Indoles
- PPAR gamma
- Phosphatidylinositol 3-Kinases
|
Topics |
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Colonic Neoplasms
(drug therapy, pathology)
- Cytokines
(genetics)
- Early Growth Response Protein 1
(genetics)
- Gene Expression Regulation
(drug effects)
- Growth Differentiation Factor 15
- Humans
- Indoles
(pharmacology)
- PPAR gamma
(agonists)
- Phosphatidylinositol 3-Kinases
- Promoter Regions, Genetic
|